Top Markets
Coin of the day
BioSyntech, Inc. BioSyntech, Inc.

BioSyntech, Inc.

BSYI
株式のランク #40152
BioSyntech, Inc. is dedicated to developing advanced biotherapeutic thermogels... BioSyntech, Inc. is dedicated to developing advanced biotherapeutic thermogels aimed at both repairing tissues and delivering therapeutic compounds. The company's key product pipeline features BST-CarGel, a biodegradable gel designed for cartilage repair; BST-InPod, intended for alleviating heel discomfort; BST-DermOn, for managing and healing chronic wounds; BST-Ossifil, used in bone void filling; BST-Ossifix, which provides structural support for bones; and BST-Disc, focused on restoring intervertebral discs. Beyond these, BioSyntech offers injectable products leveraging BST-Gel technology to precisely deliver biotherapeutics. Its technological assets also include Arthro-BST, an arthroscopic device for the non-destructive evaluation of cartilage degradation or repair, and Mach-1, a micromechanical testing system for assessing the properties of various tissues and materials. The company also manufactures ultra-pure chitosans under the Ultrasan brand and offers both manufacturing and analytical services. Founded in 1994 and based in Laval, Canada, BioSyntech Inc. initiated administration proceedings under the Bankruptcy and Insolvency Act on May 12, 2010, and is currently undergoing reorganization.
株価
$0.00001
最終同期: 2025-09-24
時価総額
$229.03K
変化(1日)
0.00%
変化(1年)
0.00%
CA
取引 BioSyntech, Inc. (BSYI)

カテゴリー

BioSyntech, Inc.(BSYI)の配当利回りの履歴
BioSyntech, Inc.(銘柄コード: BSYI)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
BioSyntech, Inc.(BSYI)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)